The overexpression of myr-AKT1 induced lipogenesis and hepatocyte proliferation, resulting in liver hepatocellular adenomas ~12 weeks post-injection and, eventually, HCC by 6 months post-injection. Here, AKT1 is linked to hepatocellular adenoma.